RESUMEN
Dendrobium（Orchidaceae） is traditional Chinese medicine with a high healthcare value，which can nourish Yin and tonify deficiency. Eighty-nine flavonoids were isolated from Dendrobium，mainly including flavones，flavanoes and flavonols. Among them，there were 40 flavonoids，the main aglycones were apigenin and chrysoeriol；20 flavanones；and 15 flavonols，and the main aglycones were kaempferol and quercetin. D. officinale and several other species also have flavanonols，anthocyanidins，chalcone and isoflavones. There were 34 species of Dendrobium containing flavonoids，including 38 flavonoids in D. officinale，28 flavonoids in D. huoshanense，19 flavonoids in D. devonianum，12 flavonoids in D. wardianum，5 flavonoids in D. thyrsiflorum，4 flavonoids in D. denneanum and D. findlayanum. Common flavonoids included naringenin，quercetin，rutin，which had pharmacological effects of resisting oxidation，lowering blood sugar，improving blood circulation，lowing cholesterol，and protecting the cardiovascular system. The existing studies of Dendrobium-related species，flavonoids and their physiological functions were reviewed in the expectation to promote the attention of the industry to Dendrobium flavonoids and explore values of Dendrobium plants in efficacy and food fields.
RESUMEN
<p><b>OBJECTIVE</b>To explore and identify the non-coding RNAs related to tumors.</p><p><b>METHODS</b>We used RT-PCR and Northern blot to analyze non-coding RNAs in tumor tissues and cell lines.</p><p><b>RESULTS</b>Two predicted non-coding RNAs were confirmed to be expressed in cancer tissues and cell lines by RT-PCR and DNA sequencing. We detected the expression of two non-coding RNA transcripts by Northern blot. The length of NC28 was about 1800 nt, and that of NC119 was about 1200nt.</p><p><b>CONCLUSIONS</b>NC28 and NC119 have a tumor-associated expression pattern. The non-coding RNAs may play a role in the development of tumors.</p>
Asunto(s)
Humanos , Línea Celular Tumoral , Neoplasias , Metabolismo , ARN no TraducidoRESUMEN
<p><b>OBJECTIVE</b>To investigate the expression status of 11 different cancer/testis (CT) antigen genes in esophageal carcinoma.</p><p><b>METHODS</b>Esophageal carcinoma tissue and adjacent normal esophageal mucosa taken from 35 esophageal carcinoma patients were assayed for the expression of 11 different CT antigen genes by RT-PCR techniques.</p><p><b>RESULTS</b>Of the 11 CT antigen genes analyzed, none of them was expressed in normal esophageal mucosa. MAGE-3 was found to be the most frequently expressed in esophageal carcinoma tissues (62.9%), followed, in the order of expression frequency, by MAGE4 (31.4%), LAGE-1 (28.6%), MAGE-1 (25.7%), CT10 (20.0%), NY-ESO-1 (20.0%), CT7 (5.7%) and SCP1 (2.9%). No expression of SSX-1, SSX-2 and SSX-4 was found. Among the 35 cases, 28 (80.0%) expressed at least one CT antigen gene, 21 (60.0%) expressed more than 2 CT antigen genes, and 4 of the 21 (19.0%) expressed more than 4 CT antigens, which accounted for 11.4% of total number of patients (4/35). No CT antigen expression was found in the tumor tissue in 7 cases, including 5 cases in stage II and 1 case each in stage I and IV, respectively. Of the 11 CT genes examined, expression of 5 genes (NY-ESO-1, LAGE-1, MAGE-1, MAGE-3 and MAGE-4) was correlated with tumor progression. SCP-1 and CT10 expression was found more frequently in early stage patients. With progression of the disease, the frequency of co-expression of multiple CT antigen genes was significantly increased reaching 28.6% in stage III patients.</p><p><b>CONCLUSION</b>Of the 11 different CT antigen genes examined by RT-PCR in esophageal carcinoma, 8 genes were detected in various frequencies in 28 of the 35 esophageal cancer patients studied. They are candidate tumor-associated antigens in the preparation of tumor vaccines for immunotherapy in esophageal cancer patients.</p>